| Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells N Bhatnagar, X Li, SKR Padi, Q Zhang, MS Tang, B Guo, ... Cell death & disease 1 (12), e105, 2010 | 233 | 2010 |
| MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice SKR Padi, Q Zhang, YM Rustum, C Morrison, B Guo Gastroenterology 145 (2), 437-446, 2013 | 140 | 2013 |
| Mmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer PS Kulkarni, MK Haldar, RR Nahire, P Katti, AH Ambre, WW Muhonen, ... Molecular pharmaceutics 11 (7), 2390-2399, 2014 | 107 | 2014 |
| Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31 Q Zhang, SKR Padi, D J Tindall, B Guo Cell Death and Disease 5, e1486, 2014 | 89 | 2014 |
| The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer N Singh, VR Ramnarine, JH Song, R Pandey, SKR Padi, N Mannan, ... Nature Communications 12, 1-20, 2021 | 52 | 2021 |
| Mechanisms behind resistance to PI3K Inhibitor treatment induced by the PIM kinase JH Song, N Singh, LA Luevano, SKR Padi, K Okumura, V Olive, SM Black, ... Molecular Cancer Therapeutics, molcanther. 0374.2018, 2018 | 42 | 2018 |
| Abstract 5820: Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset SKR Padi, L Luevano, N Singh, J Song, R Pandey, JC Aster, XZ Yu, ... Cancer Research 77 (13 Supplement), 5820, 2017 | 42* | 2017 |
| Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset SKR Padi, L Luevano, N Singh, J Song, R Pandey, JC Aster, XZ Yu, ... Oncotarget 8 (18), 30199-30216, 2017 | 42 | 2017 |
| Insulin receptor substrate 1 is a substrate of the Pim protein kinases. JH Song, SKR Padi, LA Luevano, MD Minden, DJ DeAngelo, G Hardiman, ... Oncotarget 7 (15), 20152-20165, 2016 | 28 | 2016 |
| PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth N Singh, SKR Padi, JJ Bearss, R Pandey, K Okumura, H Beltran, JH Song, ... Molecular oncology 14 (5), 974-990, 2020 | 23 | 2020 |
| Mechanism of N-acylthiourea Mediated Activation of Human Histone Deacetylase 8 (HDAC8) at Molecular and Cellular levels. DKS RK Singh, K Cho, SKR Padi, J Yu, M Haldar, T Mandal, C Yan, G Cook, B ... J Biol Chem, 2015 | 23 | 2015 |
| EDC3 phosphorylation regulates growth and invasion through controlling P‐body formation and dynamics JJ Bearss, SKR Padi, N Singh, M Cardo‐Vila, JH Song, G Mouneimne, ... EMBO reports 22 (4), e50835, 2021 | 19 | 2021 |
| Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth SKR Padi, N Singh, J Bearss, V Olive, J Song, M Cardó-Vila, A Kraft, ... Proceedings of the National Academy of Sciences 116 (41), 2019 | 19 | 2019 |
| PIM kinase inhibitors block the growth of primary T-cell acute lymphoblastic leukemia: resistance pathways identified by network modeling analysis JT Lim, N Singh, LA Leuvano, VS Calvert, EF Petricoin, DT Teachey, ... Molecular cancer therapeutics 19 (9), 1809-1821, 2020 | 6 | 2020 |
| Cryo-EM structures of PP2A: B55–FAM122A and PP2A: B55–ARPP19 SKR Padi, MR Vos, RJ Godek, JR Fuller, T Kruse, JB Hein, J Nilsson, ... Nature 625 (7993), 195-203, 2024 | 4 | 2024 |
| Oxidative Stress in Cancer: Therapeutic Implications of Small-Molecule Kinase Inhibitors SS Chauhan, N Singh, NA Warfel, SKR Padi Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, 3809-3825, 2022 | | 2022 |
| Oxidative Stress in Cancer: Therapeutic Implications of Small-Molecule Kinase Inhibitors. In: Chakraborti, S. (eds) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Chauhan S.S., Singh N., Warfel N.A., Padi S.K.R. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects., 3809–3825, 2022 | | 2022 |
| The Long Noncoding RNA H19 Regulates Tumor Plasticity in Neuroendocrine Prostate Cancer N Singh, RV Ramnarine, JH Song, R Pandey, SKR Padi, M Nouri, V Olive, ... Journal of Urology 208 (3), 729-730, 2022 | | 2022 |
| Synthesis of 2-oxoquinoline derivatives as dual pim and mTORCprotein kinase inhibitors G Gnawali, K Okumura, K Perez, R Gallagher, J Wulfkuhle, E Petricoin, ... Medicinal Chemistry Research, 2022 | | 2022 |
| Regulation of P-body dynamics and formation in tumors through EDC3 phosphorylation by PIM and AKT J Bearss, SK Padi, N Singh, M Cardo-Vila, AS Kraft, K Okumura Cancer Research 81 (13_Supplement), 2296-2296, 2021 | | 2021 |
Qunshu ZhangFDA/CDER/OND/IO/CDSAdresse e-mail validée de fda.hhs.gov
